Mike Gorenchtein, MD
Geriatric Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gorenchtein’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Original Medicare doctor bills
$64,106
Medicare paid this office $64,106 for 152 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 61 | $22,786 | $147 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 53 | $17,768 | $113 |
| New patient visit (60+ min) | 41 | $7,070 | $172 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 77 | $2,598 | $14 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,767 | $110 |
See all 9 services
| Long return visit (40+ min) | 61 | $22,786 | $147 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 53 | $17,768 | $113 |
| New patient visit (60+ min) | 41 | $7,070 | $172 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 77 | $2,598 | $14 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,767 | $110 |
| Advance care planning, first 30 minutes | 14 | $1,180 | $74 |
| Annual depression screening, 5 to 15 minutes | 30 | $651 | $22 |
| Insertion of needle into vein for collection of blood sample | 53 | $580 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $145 | $10 |
Who their Medicare patients are
152 Original Medicare patients in 2024. Average age 85 · Under 65 0% · 85 and older 48% · Women 65% · Also on Medicaid 16% · Health risk score 2.05. Above the middle of the specialty; the typical geriatric medicine clinician is at 1.84.
Conditions among them: High blood pressure 75% · Depression 51% · Dementia 49% · Coronary heart disease 38% · Diabetes 34% · Heart failure 31% · Chronic kidney disease 31% · Atrial fibrillation 31% · Stroke 29% · Cancer 23% · COPD 22%.
The office billed $367,713, Medicare allowed $84,044 and paid $64,106; for 761 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 152 | 761 | 85 | 2.05 | $367,713 | $64,106 |
| 2023 | 145 | 715 | 84 | 1.89 | $417,934 | $74,068 |
| 2022 | 33 | 95 | 83 | 1.82 | $51,303 | $9,333 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Long return visit (40+ min) | 67 | $27,589 | $156 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 51 | $20,673 | $113 |
| New patient visit (60+ min) | 59 | $10,074 | $171 |
| Transitional care management services for problem of high complexity | 11 | $2,753 | $250 |
| Advance care planning, first 30 minutes | 22 | $1,996 | $74 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,716 | $114 |
| Insertion of needle into vein for collection of blood sample | 58 | $890 | $8 |
| Influenza vaccine split virus, preservative free | 11 | $791 | $72 |
| Annual depression screening, 5 to 15 minutes | 36 | $760 | $21 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $458 | $29 |
| Administration of influenza virus vaccine | 11 | $396 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $213 | $13 |
2022: 3 services
| Long return visit (40+ min) | 15 | $3,324 | $166 |
| New patient visit (60+ min) | 11 | $2,120 | $193 |
| Insertion of needle into vein for collection of blood sample | 17 | $59 | $3 |
Medicaid work
$907 in 2023
Medicaid paid $907 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $907 |
| 2023 | 13 | 1 | 13 | $907 |
Drugs they prescribed that Part D paid
$215,988
Pharmacies billed $215,988 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,558 generic and fewer than 11 brand-name prescriptions · $215,988 in drug cost · 29 antibiotic prescriptions to 23 people · 50 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 50 | $59,622 | $1,192 |
| Breo Ellipta | 23 | $8,983 | $391 |
| Memantine Hcl Er | 16 | $8,968 | $560 |
| Januvia | 14 | $8,741 | $624 |
| Rivastigmine | 12 | $6,513 | $543 |
See all 46 drugs
| Eliquis | 50 | $59,622 | $1,192 |
| Breo Ellipta | 23 | $8,983 | $391 |
| Memantine Hcl Er | 16 | $8,968 | $560 |
| Januvia | 14 | $8,741 | $624 |
| Rivastigmine | 12 | $6,513 | $543 |
| Duloxetine | 25 | $3,632 | $145 |
| Quetiapine | 38 | $2,136 | $56 |
| Escitalopram | 69 | $1,877 | $27 |
| Atorvastatin | 88 | $1,743 | $20 |
| Levothyroxine | 88 | $1,615 | $18 |
| Midodrine | 16 | $1,519 | $95 |
| Ondansetron Odt | 11 | $1,321 | $120 |
| Metoprolol | 66 | $1,287 | $20 |
| Amlodipine Besylate | 124 | $1,199 | $10 |
| Amiodarone | 13 | $1,007 | $77 |
| Losartan | 78 | $862 | $11 |
| Rosuvastatin | 27 | $783 | $29 |
| Sertraline | 35 | $782 | $22 |
| Ammonium Lactate | 23 | $780 | $34 |
| Memantine | 16 | $776 | $49 |
| Lidocaine | 12 | $728 | $61 |
| Mirtazapine | 14 | $658 | $47 |
| Valsartan | 11 | $643 | $58 |
| Donepezil | 28 | $552 | $20 |
| Synthroid | 12 | $544 | $45 |
| Gabapentin | 15 | $491 | $33 |
| Omeprazole | 22 | $482 | $22 |
| Albuterol Sulfate Hfa | 21 | $467 | $22 |
| Pantoprazole | 23 | $454 | $20 |
| Trazodone | 19 | $441 | $23 |
| Citalopram Hbr | 16 | $424 | $27 |
| Lantus Solostar | 12 | $424 | $35 |
| Famotidine | 26 | $399 | $15 |
| Metformin | 32 | $396 | $12 |
| Tamsulosin | 23 | $371 | $16 |
| Clopidogrel | 12 | $347 | $29 |
| Losartan-Hydrochlorothiazide | 20 | $338 | $17 |
| Simvastatin | 22 | $304 | $14 |
| Allopurinol | 11 | $224 | $20 |
| Propranolol | 11 | $222 | $20 |
| Lisinopril | 21 | $220 | $10 |
| Diclofenac | 11 | $209 | $19 |
| Alprazolam | 11 | $156 | $14 |
| Furosemide | 20 | $118 | $6 |
| Hydrochlorothiazide | 30 | $75 | $2 |
| Carvedilol | 14 | $25 | $2 |
Year by year
| 2024 | 1,812 | 199 | None | None | $215,988 |
| 2023 | 1,208 | 174 | 1% (12) | None | $107,214 |
| 2022 | 291 | 96 | None | 13% | $23,518 |
| 2021 | 302 | 80 | None | None | $14,385 |
| 2020 | 74 | 35 | 0% (0) | 16% | $4,469 |
| 2019 | 36 | 12 | 0% (0) | None | $3,054 |
| 2018 | 219 | 33 | 0% (0) | None | $19,238 |
| 2017 | 16 | None | 0% (0) | None | $8,328 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Eliquis | 32 | $26,752 | $836 |
| Memantine | 18 | $2,276 | $126 |
| Atorvastatin | 68 | $1,332 | $20 |
| Valsartan | 20 | $960 | $48 |
| Metoprolol | 32 | $817 | $26 |
| Donepezil | 24 | $799 | $33 |
| Levothyroxine | 40 | $772 | $19 |
| Quetiapine | 49 | $712 | $15 |
| Duloxetine | 18 | $687 | $38 |
| Albuterol Sulfate Hfa | 22 | $685 | $31 |
| Amlodipine Besylate | 96 | $683 | $7 |
| Diclofenac | 25 | $675 | $27 |
| Escitalopram | 41 | $612 | $15 |
| Mirtazapine | 16 | $449 | $28 |
| Losartan | 26 | $441 | $17 |
| Rosuvastatin | 11 | $418 | $38 |
| Omeprazole | 19 | $410 | $22 |
| Trazodone | 30 | $323 | $11 |
| Lisinopril | 26 | $323 | $12 |
| Gabapentin | 19 | $309 | $16 |
| Metformin | 19 | $304 | $16 |
| Simvastatin | 12 | $282 | $23 |
| Ondansetron Odt | 12 | $262 | $22 |
| Tamsulosin | 13 | $242 | $19 |
| Clonazepam | 14 | $214 | $15 |
| Fluticasone Propionate | 19 | $213 | $11 |
| Pantoprazole | 13 | $188 | $14 |
| Paroxetine | 11 | $179 | $16 |
| Famotidine | 15 | $166 | $11 |
| Furosemide | 14 | $105 | $8 |
| Hydrochlorothiazide | 14 | $40 | $3 |
2022: 4 drugs
| Atorvastatin | 25 | $649 | $26 |
| Diclofenac | 12 | $261 | $22 |
| Valsartan-Hydrochlorothiazide | 13 | $119 | $9 |
| Amlodipine Besylate | 16 | $76 | $5 |
2021: 6 drugs
| Metoprolol | 18 | $275 | $15 |
| Atorvastatin | 21 | $162 | $8 |
| Pantoprazole | 14 | $115 | $8 |
| Amlodipine Besylate | 16 | $96 | $6 |
| Sertraline | 21 | $81 | $4 |
| Tamsulosin | 11 | $73 | $7 |
2018: 4 drugs
| Brilinta | 15 | $5,396 | $360 |
| Atorvastatin | 32 | $345 | $11 |
| Pantoprazole | 12 | $79 | $7 |
| Torsemide | 11 | $56 | $5 |
Money from drug and device companies
$348 in 2025
| 2025 | 12 | 17 | None | $348 |
| 2024 | 4 | 7 | None | $227 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Mounjaro | $50 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $49 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $47 | 2 payments
|
| Novo Nordisk | Wegovy | $34 | 2 payments
|
| Abbvie | Vraylar | $28 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $25 | 1 payment
|
See all 17 published payments
| Amgen | Meals · 2025-10-22 | Repatha | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-25 | Kerendia | $20 |
| Exact Sciences | Meals · 2025-09-14 | Cologuard Collection Kit | $25 |
| GlaxoSmithKline | Meals · 2025-08-27 | Arexvy | $22 |
| Abbvie | Meals · 2025-07-08 | Vraylar | $28 |
| Lilly USA | Meals · 2025-06-17 | Mounjaro | $20 |
| Pfizer | Meals · 2025-05-14 | Paxlovid | $22 |
| Currax Pharmaceuticals | Meals · 2025-04-23 | Contrave | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-09 | Trintellix | $30 |
| Novo Nordisk | Meals · 2025-04-07 | Wegovy | $15 |
| Hologic Sales and Service | Meals · 2025-03-26 | Acessa Provu System | $22 |
| CooperSurgical | Meals · 2025-03-04 | Paragard T 380a | $17 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-26 | Trintellix | $19 |
| Novo Nordisk | Meals · 2025-02-20 | Wegovy | $19 |
| Lilly USA | Meals · 2025-02-07 | Mounjaro | $15 |
| GlaxoSmithKline | Meals · 2025-02-03 | Trelegy Ellipta | $26 |
| Lilly USA | Meals · 2025-01-09 | Mounjaro | $15 |
See earlier years (2024)
2024: $227
| Abbvie | Qulipta | $136 | 3 payments
|
| Novo Nordisk | Wegovy | $48 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $27 | 1 payment
|
| Bioventus | Durolane | $16 | 1 payment
|
Professional record
- NPI
- 1326571217
- Licence
- NY 316892
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 221 E Hacienda Ave Ste B, Campbell, CA, 95008
- NPI first listed
- 2017-04-06
- NPI last updated
- 2025-10-09
- NPI record certified
- 2025-10-09
This is when the NPI record was last certified, not a medical board exam.